Related Experiment Video
Updated: Feb 17, 2026

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
Published on: March 21, 2025
Assemblies of amyloid-β30-36 hexamer and its G33V/L34T mutants by replica-exchange molecular dynamics simulation
Zhenyu Qian1, Qingwen Zhang2, Yu Liu1
1Key Laboratory of Exercise and Health Sciences (Ministry of Education) and School of Kinesiology, Shanghai University of Sport, Shanghai, China.
Abstract:
The aggregation of amyloid-β peptides is associated with the pathogenesis of Alzheimer's disease, in which the 30-36 fragments play an important part as a fiber-forming hydrophobic region. The fibrillar structure of Aβ30-36 has been detected by means of X-ray diffraction, but its oligomeric structural determination, biophysical characterization, and pathological mechanism remain elusive. In this study, we have investigated the structures of Aβ30-36 hexamer as well as its G33V and L34T mutants in explicit water environment using replica-exchange molecular dynamics (REMD) simulations. Our results show that the wild-type (WT) Aβ30-36 hexamer has a preference to form β-barrel and bilayer β-sheet conformations, while the G33V or L34T mutation disrupts the β-barrel structures: the G33V mutant is homogenized to adopt β-sheet-rich bilayers, and the structures of L34T mutant on the contrary get more diverse. The hydrophobic interaction plays a critical role in the formation and stability of oligomeric assemblies among all the three systems. In addition, the substitution of G33 by V reduces the β-sheet content in the most populated conformations of Aβ30-36 oligomers through a steric effect. The L34T mutation disturbs the interpeptide hydrogen bonding network, and results in the increased coil content and morphological diversity. Our REMD runs provide structural details of WT and G33V/L34T mutant Aβ30-36 oligomers, and molecular insight into the aggregation mechanism, which will be helpful for designing novel inhibitors or amyloid-based materials.
Insights
Alzheimer's disease involves amyloid-β peptide aggregation. This study used molecular dynamics to reveal how mutations in Aβ30-36 fragments affect oligomer structure and aggregation, offering insights for new treatments.
Area of Science:
- Biochemistry
- Molecular Biology
- Computational Biophysics
Background:
- Amyloid-β (Aβ) peptide aggregation is central to Alzheimer's disease pathogenesis.
- The Aβ30-36 fragment is a key hydrophobic region involved in fibril formation.
- Oligomeric structures and aggregation mechanisms of Aβ30-36 remain poorly understood.
Purpose of the Study:
- To investigate the structural conformations of wild-type (WT) Aβ30-36 hexamer and its G33V and L34T mutants.
- To elucidate the role of hydrophobic interactions and specific mutations in Aβ30-36 oligomerization.
- To provide molecular insights into the aggregation mechanisms relevant to Alzheimer's disease.
Main Methods:
- Replica-exchange molecular dynamics (REMD) simulations in an explicit water environment.
- Analysis of structural preferences (β-barrel, β-sheet, coil) and conformational diversity.
- Assessment of hydrophobic interactions and interpeptide hydrogen bonding networks.
Main Results:
- WT Aβ30-36 hexamer favors β-barrel and bilayer β-sheet structures.
- G33V mutation leads to homogenized β-sheet-rich bilayers, disrupting β-barrels.
- L34T mutation increases structural diversity and coil content by disturbing hydrogen bonds.
Conclusions:
- Hydrophobic interactions are critical for Aβ30-36 oligomer formation and stability.
- Specific mutations (G33V, L34T) significantly alter Aβ30-36 oligomer structures and aggregation pathways.
- These findings offer molecular insights valuable for designing inhibitors or amyloid-based materials.
More Related Videos
06:34A Tailored HPLC Purification Protocol That Yields High-purity Amyloid Beta 42 and Amyloid Beta 40 Peptides, Capable of Oligomer Formation
Published on: March 27, 2017
14:55Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
Published on: September 17, 2017
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils